Graf Acquisition Corp. IV (GFOR) Adds FPA to NKGen Biotech Dealby Nicholas Alan Clayton published 5 hours ago

Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that it has come to a forward purchase agreement (FPA) with Meteora Capital Partners involving up to 2,500,000 shares for its combination with NKGen Biotech. Meteora is to purchase up to that amount on the open market prior to close, capped at 9.9% of...

The Latest Liquidations: September 21, 2023

Marvin 2023-09-21 at 5:38pm


Copyright © 2023 SPACInsider, Inc. All Rights Reserved